Compare Stryker Corporation (SYK) vs UBS Group AG Registered Ordinary Shares (UBS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Stryker Corporation vs UBS Group AG Registered Ordinary Shares — how do they compare? Stryker Corporation trades at $278.84 (market cap $106.24B), while UBS Group AG Registered Ordinary Shares trades at $47.97 (market cap $142.70B). The key difference: UBS Group AG Registered Ordinary Shares is the larger of the two by market cap, and UBS Group AG Registered Ordinary Shares pays the higher dividend (2.34%). Which is the better fit depends on your goals — on Pluang, investors hold Stryker Corporation for 20 Days and UBS Group AG Registered Ordinary Shares for 0 Days on average.
| SYK | UBS | |
|---|---|---|
Market Cap | $106.24B | $142.70B |
Volume | 2,982,001 | 2,096,090 |
Sector | Health | Financials |
52-Week High | $388.35 | $55.72 |
52-Week Low | $269.75 | $36.41 |
Typical Hold Time | 20 Days | 0 Days |
Enterprise Value | $117.70B | $314.41B |
Dividend Yield | 1.27% | 2.34% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Stryker (SYK) trades at $279.15, up 1.36% on the day, amid a mixed technical and fundamental backdrop. The stock shows bearish technical signals with key support at $268 and resistance at $284, while fundamentals remain solid with a 14.43% net income margin and strong analyst consensus of 71% buy ratings. Recent news highlights ongoing legal scrutiny over manufacturing issues, but the company maintains robust cash flow and earnings growth, with Q3 2026 results pending.
Outlook: SYK offers growth potential with a consensus price target of $368.11, supported by profitability and innovation, but faces near-term risks from legal investigations and technical weakness. Investors should weigh strong fundamentals against sentiment headwinds.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →About UBS Group AG Registered Ordinary Shares
UBS is a global financial services company focused on wealth management, investment banking, and asset management. It serves private, corporate, and institutional clients.
Read more on UBS →
